Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00230685 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment target: 500 to 2000 Primary and study completion dates: Jan 2018 to Jan 2028 · Study description expanded, about 81 words · Publications: 9 to 23v4 Show 3 more changesShow less
    • Primary and study completion dates: Jan 2018 to Jan 2028
    • Study description expanded, about 81 words
    • Publications: 9 to 23

    See this version in full on ClinicalTrials.gov ↗

  2. Primary and study completion dates: Jan 2018 Publications: 1 to 9v3 Show 1 more changeShow less
    • Publications: 1 to 9

    See this version in full on ClinicalTrials.gov ↗

  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This observational study is for individuals with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that are reviewed at the Hammersmith Hospital, London.
Trial Details
NCT Number NCT00230685
Lead Sponsor Imperial College London
Collaborators: The Margaret Hayton HHT Fund
Conditions Telangiectasia, Hereditary Hemorrhagic
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov